168 related articles for article (PubMed ID: 36511578)
21. Circulating microRNAs in gallbladder cancer: Is serum assay of diagnostic value?
Srivastava P; Mishra S; Agarwal A; Pandey A; Husain N
Pathol Res Pract; 2023 Feb; 242():154320. PubMed ID: 36682281
[TBL] [Abstract][Full Text] [Related]
22. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
23. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
24. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
[TBL] [Abstract][Full Text] [Related]
25. Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients.
Huo D; Clayton WM; Yoshimatsu TF; Chen J; Olopade OI
Oncotarget; 2016 Aug; 7(34):55231-55248. PubMed ID: 27409424
[TBL] [Abstract][Full Text] [Related]
26. Circulating microRNA-339-5p and -21 in plasma as an early detection predictors of lung adenocarcinoma.
Sun Y; Mei H; Xu C; Tang H; Wei W
Pathol Res Pract; 2018 Jan; 214(1):119-125. PubMed ID: 29103767
[TBL] [Abstract][Full Text] [Related]
27. microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection.
Hamam R; Ali AM; Alsaleh KA; Kassem M; Alfayez M; Aldahmash A; Alajez NM
Sci Rep; 2016 May; 6():25997. PubMed ID: 27180809
[TBL] [Abstract][Full Text] [Related]
28. Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine.
Lin JT; Tsai KW
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924142
[TBL] [Abstract][Full Text] [Related]
29. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
30. Absolute quantification of cell-free microRNAs in cancer patients.
Ferracin M; Lupini L; Salamon I; Saccenti E; Zanzi MV; Rocchi A; Da Ros L; Zagatti B; Musa G; Bassi C; Mangolini A; Cavallesco G; Frassoldati A; Volpato S; Carcoforo P; Hollingsworth AB; Negrini M
Oncotarget; 2015 Jun; 6(16):14545-55. PubMed ID: 26036630
[TBL] [Abstract][Full Text] [Related]
31. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer.
Halvorsen AR; Bjaanæs M; LeBlanc M; Holm AM; Bolstad N; Rubio L; Peñalver JC; Cervera J; Mojarrieta JC; López-Guerrero JA; Brustugun OT; Helland Å
Oncotarget; 2016 Jun; 7(24):37250-37259. PubMed ID: 27191990
[TBL] [Abstract][Full Text] [Related]
32. Identification of four serum miRNAs as potential markers to screen for thirteen cancer types.
Chen JW; Dhahbi J
PLoS One; 2022; 17(6):e0269554. PubMed ID: 35687572
[TBL] [Abstract][Full Text] [Related]
33. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
34. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
35. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
36. Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer.
Vychytilova-Faltejskova P; Radova L; Sachlova M; Kosarova Z; Slaba K; Fabian P; Grolich T; Prochazka V; Kala Z; Svoboda M; Kiss I; Vyzula R; Slaby O
Carcinogenesis; 2016 Oct; 37(10):941-950. PubMed ID: 27485599
[TBL] [Abstract][Full Text] [Related]
37. Altered editing level of microRNAs is a potential biomarker in lung adenocarcinoma.
Maemura K; Watanabe K; Ando T; Hiyama N; Sakatani T; Amano Y; Kage H; Nakajima J; Yatomi Y; Nagase T; Takai D
Cancer Sci; 2018 Oct; 109(10):3326-3335. PubMed ID: 30022565
[TBL] [Abstract][Full Text] [Related]
38. Circulating miR-21-5p and miR-126-3p: diagnostic, prognostic value, and multivariate analysis in non-small-cell lung cancer.
Soliman SE; Abdelaleem AH; Alhanafy AM; Ibrahem RAL; Elhaded ASA; Assar MFA
Mol Biol Rep; 2021 Mar; 48(3):2543-2552. PubMed ID: 33837901
[TBL] [Abstract][Full Text] [Related]
39. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
[TBL] [Abstract][Full Text] [Related]
40. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
